1. Home
  2. ALLO vs DDL Comparison

ALLO vs DDL Comparison

Compare ALLO & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$0.76

Market Cap

452.6M

Sector

Health Care

ML Signal

HOLD

Logo Dingdong (Cayman) Limited (each two representing three)

DDL

Dingdong (Cayman) Limited (each two representing three)

SELL

Current Price

$1.73

Market Cap

494.2M

ML Signal

SELL

Company Overview

Basic Information
Metric
ALLO
DDL
Founded
2017
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
452.6M
494.2M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ALLO
DDL
Price
$0.76
$1.73
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $9.00
N/A
AVG Volume (30 Days)
★ 11.2M
297.6K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 34.09
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.28
Revenue Next Year
$72.02
$9.66
P/E Ratio
★ N/A
$16.08
Revenue Growth
N/A
★ N/A
52 Week Low
$0.74
$1.69
52 Week High
$4.46
$3.41

Technical Indicators

Market Signals
Indicator
ALLO
DDL
Relative Strength Index (RSI) 21.26 33.65
Support Level N/A N/A
Resistance Level $2.25 $2.58
Average True Range (ATR) 0.10 0.10
MACD -0.02 -0.01
Stochastic Oscillator 0.42 6.67

Price Performance

Historical Comparison
ALLO
DDL

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd are a foremost fresh grocery e-commerce company in mainland China with sustainable growth. It directly provide users and households with fresh groceries, prepared food and other food products through delivering a convenient and excellent shopping experience supported by an extensive self-operated frontline fulfillment grid. The Group operates and manages its business as a single segment. The Group generates substantially all of its revenues from customers in the PRC.

Share on Social Networks: